Alere NT-proBNP for Alinity i
Test, Natriuretic Peptide. 510(k) K253539, from Axis-Shield Diagnostics, Ltd. (Dundee, GB). Product code NBC, class 2.
As of Nov 19, 2026, K253539 is an FDA 510(k) held by Axis-Shield Diagnostics, Ltd., substantially equivalent on Feb 18, 2026 after 97 days, with no recalls tied to it in FDA's recall database.
- Review time: 97 days
- Recalls: 0
The Alere NT-proBNP for Alinity i assay is a chemiluminescent microparticle immunoassay (CMIA) used for the in vitro quantitative determination of N-terminal pro B-type natriuretic peptide (NT-proBNP) in human serum and plasma on the Alinity i system.
- Elecsys Probnp Ii Stat Immunoassay and Elecsys Probnp Ii Calset, Models 05390109-160, 04842472-190K092649 · Roche Diagnostics Corp. · Feb 4, 2010
- Access BNP IIK262597 · Beckman Coulter, Inc. · Oct 20, 2026
- Access NT-proBNPK262109 · Beckman Coulter, Inc. · Sep 21, 2026
- Access BNP IIK252169 · Beckman Coulter, Inc. · Mar 24, 2026
- Alere NT-proBNP for Alinity i Reagent KitK241176 · Axis-Shield Diagnostics, Ltd. · Jan 16, 2025
- Access NT-proBNPK232164 · Beckman Coulter, Inc. · Apr 12, 2024
- ADVIA Centaur® NT-proBNPII (PBNPII)K220265 · Siemens Healthcare Diagnostics, Inc. · Sep 24, 2023
- Elecsys proBNP II, Elecsys proBNP II STATK223637 · Roche Diagnostics · Jul 21, 2023
- Elecsys proBNP II, Elecsys proBNP II STATK210546 · Roche Diagnostics · Mar 31, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 13, 2025
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1117
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files